Format

Send to

Choose Destination
See comment in PubMed Commons below
Cardiol Clin. 2008 May;26(2):157-67, v. doi: 10.1016/j.ccl.2007.12.010.

Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.

Author information

1
Albert Einstein College of Medicine and Montefiore Medical Center, 111 East 210 Street, Bronx, NY 10467, USA. lajacobs@montefiore.org

Abstract

Warfarin, a vitamin K antagonist, is currently the most extensively used oral anticoagulant world-wide. It is prescribed for a variety of indications and has undergone extensive clinical study. Still, despite wide usage and considerable accumulated data from clinical trials demonstrating efficacy for a variety of thrombotic and thromboembolic conditions, warfarin is underutilized because its management is complex for both patients and physicians. However, despite these limitations, warfarin can be managed with relative safety, even in an elderly population.

PMID:
18406992
DOI:
10.1016/j.ccl.2007.12.010
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center